| Systematic (IUPAC) name | |
|---|---|
| 3-hydroxy- 14-methoxy- 5,17-dimethyl- 7,8-dihydro- 4,5α- epoxy- morphinan- 6-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 131575-03-6 |
| ATC code | ? |
| PubChem | CID 5486940 |
| ChemSpider | 4589140 |
| ChEMBL | CHEMBL326684 |
| Synonyms | 14-Methoxymetopon |
| Chemical data | |
| Formula | C19H23NO4 |
| Mol. mass | 329.39 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
14-Methoxymetopon is an opiate analogue that is a derivative of metopon which has been substituted with a methoxy group at the 14-position. It is a highly potent analgesic drug that is around 500x stronger than morphine when administered systemically; however, when given spinally or supraspinally, it exhibits analgesic activity up to a million fold greater than morphine.[1] It binds strongly to the μ-opioid receptor and activates it to a greater extent than most similar opioid drugs.[2] This produces an unusual pharmacological profile, and although 14-methoxymetopon acts as a potent μ-opioid full agonist in regards to some effects such as analgesia, a ceiling effect is seen on other effects such as constipation and respiratory depression.[3]
| This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)